Special Offering :
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
The Europe Molecular Diagnostics Market Size is would grow at a growth rate of 7.8% CAGR during the forecast period (2016 - 2022).
Molecular Diagnostics is used to identify or monitor biomarkers associated with any particular diseases or conditions. This test could also help in detecting and quantifying the presence of specific bacteria and viruses. These devices help surgeons in deciding that which therapy would work best on different patients. Molecular Diagnostics detect the diseases by analyzing RNA (Ribonucleic Acid) or DNA (Deoxyribonucleic Acid) in humans.
These diagnostics are mainly used for clinical testing devices that are supplied in clinics, hospitals, laboratories, and research institutes. In Europe, Advances in Prenatal Molecular Diagnostics, Biomarkers for Immunotherapy, Advanced diagnostics for Infectious diseases, Point to care diagnostics, Cell free DNA in clinical oncology is playing vital role in the growth of molecular diagnostics market. According to the fourth conference on molecular diagnostics Europe held in 2016, it has been stated that arrays and next-gen sequencing are playing an increased role in the level of invasive technology.
Also, it is contributing towards the increasing demand for DNA. In Addition, Cambridge Healthtech Institute has designed Inaugural Biomarkers for Immunotherapy. On the other side many health companies are also offering new range of products with molecular technologies. For Example: Siemens Healthcare has also launched its new product with new VERSANT? kPCR Molecular System. This product improves workflow and consolidation and allows multiple assays per sample and run.
Recently, Microbix has also launched new range of products in molecular diagnostics. Hence, it could be expected that innovative technology could be leading the growth of molecular diagnostics market in Europe. The Molecular Diagnostics Market is segmented on the basis of Product & Services, Technology, Application, End-user and Region. Based on Product & Services, the market is segmented into instruments, reagents & Kits, and software & services. Reagents & Kits is expected to gather largest share in the market due to rising demand of reagents in clinical centers and diagnostics centers. Based on Technology, market is segmented into Polymerase Chain Reaction (PCR), Microarray, Isothermal Nucleic Acid Amplification Technology (INAAT), Hybridization, Microarray, DNA Sequencing and Next-Generation Sequencing.
Based on Application, the market is segmented into six types such as Infectious diseases molecular testing, Molecular oncology testing, Inherited diseases molecular testing, Identity testing, Tissue type testing and Pharmacogenetics testing. Infectious Diseases includes Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG), Human Papillomavirus (HPV), Human Immunodeficiency Virus (HIV), Tuberculosis (TB), Hepatitis B, Hepatitis C, Tuberculosis (TB), Methicillin-Resistant Staphylococcus Aureus (MRSA) and other infectious diseases. On the other hand, oncology is further divided into Breast Cancer, Prostate Cancer, Colorectal Cancer and others.
The infectious diseases molecular testing is mostly preferred in the hospitals and clinical centers. Based on End-User, the market is segmented into i clinics, hospitals, laboratories, and research institutes. Based on Country, market is segmented into Germany, UK, France, Russia, Spain and Italy.The report covers the analysis of key stake holders of the Molecular Diagnostics market. Key companies profiled in the report include Abbott Laboratories, Qiagen N.V, Roche Diagnostics, Grifols, Siemens Healthcare (Siemens AG), Becton Dickinson and Company and Danaher Corporation.